Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma‐related interstitial lung disease developed by PSGL‐1 deficient mice
González‐Sánchez, Elena, Muñoz‐Callejas, Antonio, Gómez‐Román, Javier, San Antonio, Esther, Marengo, Alessandro, Tsapis, Nicolas, Bohne‐Japiassu, Kamila, González‐Tajuelo, Rafael, Pereda, Saray, García‐Pérez, Javier, Cavagna, Lorenzo, González‐Gay, Miguel Ángel, Vicente‐Rabaneda, Esther Francisca, Meloni, Federica, Fattal, Elias, Castañeda, Santos, Urzainqui, Ana
Published in British journal of pharmacology (01.09.2022)
Published in British journal of pharmacology (01.09.2022)
Get full text
Journal Article